QMS regulation in Japan. Office of Manufacturing/Quality and Compliance As of 1st April, 2015

Similar documents
Current Situation and Updates of QMS Inspection in Japan. Office of GMP/QMS Inspection Pharmaceuticals and Medical Devices Agency

QMS (Quality Management System) for Medical Device in Japan

Japan Update - Implementation of PMD Act - March, 2015

Trial acceptance of MDSAP audit reports in Japan

Implementation of 2005 Pharmaceutical Affairs Law and ICH Q8-Q10 in Japan

Current GMP Inspection of PMDA. Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN

Contents. Regulatory Bodies... 13

1. GMP/Quality issues Report back from the discussion in last year s symposium

Regulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance

Question & Answer for Challenges in Product Registration Process for Medical Device in Taiwan and Japan.

Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil)

MDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc.

Medical Device Product Innovation

IVD Inspections Technical Update Dr Dragana Milic Medical devices inspections

Handling of Marketing Application for Combination Products

Pharmaceutical Regulations in Japan

Contents. 1. Administrative Organizations and Affairs under Jurisdiction for Veterinary Medical Devices

Comparative Overview of Other Medical Devices Regulatory Systems

Progress of QMS/QSD WG

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015

INFORMATION ON JAPANESE REGULATORY AFFAIRS

Korean Medical Devices Regulations

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Q and A on Application of PIC/s GMP Guide

Supplier Audit Procedure /2/17

Tuesday, 21 October Jang Yong Choi

Korea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon

ABRIDGED PREQUALIFICATION ASSESSMENT. Prequalification of In Vitro Diagnostics

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015

Page 1 / 11. Version 0 June 2014

Supplier Audit Procedure /20/17

Medical Device Single Audit Program (MDSAP)

Korea Medical Device Regulatory Requirements Update

Satellite Aerospace, Inc. TERMS & CONDITIONS Page 1 of 6

DRUG DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009

QM-1 QUALITY MANAGEMENT SYSTEMS MANUAL. Revision 10

Post-Approval CMC Changes in Japan: How We Envision the Future

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01

To: Prefectural Governors From: Director-General, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare

MDSAP Me M dical D e D vice S i S ngle Audit Program

CHAPTER 2 PHARMACEUTICAL LAWS AND REGULATIONS 1. PHARMACEUTICAL LAWS 2. PHARMACEUTICAL AND MEDICAL DEVICE ACT

Current Situation of Regulations and Premarket Review in Future of Companion Diagnostics in Japan

Conditional Early Approval System for Innovative Medical Device Products (Fast-Break Scheme)

TURBO MACH A DIVISION OF VT SAA

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Post approval change of Japanese registration dossiers and impact on market supply

Risk based approaches in the Japan-GMP Regulation

Your Vision, Our Future Korean Medical Device Your Vision, Our Future

Med-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH

UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS

Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience

QUALITY MANUAL QM0492 ISO SUPPLEMENT III

QMS-002. Quality Management System Manual. Conforms to ISO 13485

Index Day reports (ADR)...59, 125

Regulatory Perspectives of Japan

Prequalification of in vitro diagnostics - Technical Update 24 November 2015

New Direction of Japanese Regulations on MD/IVD. - Japan Update -

SCHEDULE M-III [See Rule 76]

Materials Management Traceability, CEPs and managing non-conforming sites

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM

Med-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH

PROPOSED DOCUMENT. Global Harmonization Task Force

Wilson-Hurd ATF Quality Manual

Standard and Directives on Medical Devices

Medical Devices 6 Step Guide to Global Markets:

Pharmaceutical Regulations in Japan

MEDICINES CONTROL COUNCIL

AAMI Quality Systems White Paper

HACCPEUROPA PUBLICATIONS ISO 22000:2005 FOOD SAFETY QUALITY MANUAL. ISO 22000:2005 Quality Manual

Satellite Aerospace, Inc. TERMS & CONDITIONS Page 1 of 5

Complete global Solutions

CHAPTER 2 PHARMACEUTICAL LAWS AND REGULATIONS 1. PHARMACEUTICAL LAWS 2. PHARMACEUTICAL AND MEDICAL DEVICE ACT

David W Feigal, Jr., MD MPH

Report on the Status of UDI in Japan. The Japan Federation of Medical Devices Associations UDI Committee July 3, 2018

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

WHO Prequalification of In Vitro Diagnostics Programme

Document Type: Main Process: Revision Level: Page: POLICY QUALITY ASSURANCE 3 1 of 6 Process Owner Title:

Staffing - Medical Devices

Korea's Medical Device Regulatory Structure - Introduction

LAW ON STANDARDS AND TECHNICAL REGULATIONS

In the huge expanse of Asia, Singapore and

PMDA Update: Its current situation and future direction

PART I REQUIREMENTS FOR ORGANIZATIONS THAT REQUIRE CERTIFICATION

INFORMATION IN ENGLISH ON JAPAN REGULATORY AFFAIRS. English Regulatory Information Task Force, Japan. Pharmaceutical Manufacturers Association

San Jose, California, USA

Food Safety Quality Management System

QUALITY MANUAL ECO# REVISION DATE MGR QA A 2/25/2008 R.Clement J.Haislip B 6/17/2008 T.Finneran J.Haislip

PMDA Perspective: Recent Trends in the Regulation of Biopharmaceuticals

ANCHOR ISO9001:2008 RPR-006 MARINE SERVICES REQUIRED PROCEDURE PREVENTATIVE ACTION

5 Countries. 1 Unified Audit.

Prevent Quality System Deficiencies by Conducting Effective Internal Audits. Whitepaper

CO-ORDINATION OF NOTIFIED BODIES PPE Regulation 2016/425 RECOMMENDATION FOR USE

NMT Specialized Machining Inc & NMT General Machining Inc AS 9100 Rev C Quality Systems Manual

BAM-GGR 001 Part A Manufacturing and remanufacturing

ISO 9001 PMA and 14 CFR 21 QUALITY POLICIES HANDBOOK

UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD)

AUNA Supplier Quality Manual

GCP/Clinical Investigation in Japan

MDSAP Overview Marseille,

Transcription:

QMS regulation in Japan Office of Manufacturing/Quality and Compliance As of 1st April, 2015

Manufacturing/Quality and Compliance Manufacturing/Quality and Compliance QA of GMP/QMS GMP QMS KANSAI Branch http://www.pmda.go.jp/english /about-pmda/outline/0003.html RCB supervision Issued on 1st April, 2015. 1

Main Topics 1. Definition 2. Overview of QMS regulation change 3. Type of QMS inspection 4. Scope of mfg. site registration and QMS inspection 5. QMS inspection p.3 p.6 p.8 p.12 p.22 5.1. Application of QMS 5.2. Determination of on-site or desktop inspection 5.3. On-site inspection 5.4. Desktop inspection 5.5. Conformity assessment p.25 p.28 p.31 p.36 p.39 Issued on 1st April, 2015. 2

1. Definition Issued on 1st April, 2015. 3

License, Registration, Approval 1.Definition Marketing license a requirement for marketing any medical devices and IVDs in Japan. Thus, all the marketing authorization holders (MAHs) shall have this license. Manufacturing site registration ( Toroku ) a requirement for conducting specified manufacturing processes. In the case of medical devices, design, main assembling, sterilization and domestic (Japan) distribution site shall be registered. Marketing approval ( Shonin ) a requirement for any medical devices and IVDs marketed in Japan. When applying for marketing approval of a new medical device or IVD or partial changes of authorized items hereto, QMS inspection application is also required. The QMS inspection application is required every 5 years to maintain existing marketing approval. Issued on 1st April, 2015. 4

Exceptional Marketing Authorization Marketing Authorization Holder : MAH ( Seihan ) A person who obtains the marketing license. MAH shall supervise and manage the manufacturer, and ensure the compliance with QMS of all manufacturing sites. Ensure proper product release to the market. MAH must be based in Japan. Foreign restrictive authorization holder : FRAH A foreign manufacturer who obtains the marketing approvals of medical devices in foreign country. FRAH may designate licensed MAH in Japan and have it market the product. Designated MAH : DMAH ( Sennin seihan ) MAH designated by FRAH to conduct required quality control duties inside Japan. FRAH shall have D-MAH take necessary measures for the prevention of occurrence of hazards to the public health and hygiene in Japan caused by the product. MAH marketing authorization domestic quality control duties FRAH marketing authorization + DMAH domestic quality control duties 1.Definition Issued on 1st April, 2015. 5

2. Overview of QMS Regulation Change Issued on 1st April, 2015. 6

2.Overview of QMS regulation change QMS regulation change under the revision of PAL Revised law went into effect in 25th Nov. 2014. Change of QMS inspection authority (see topic 3) Scope of Certification Standards will be expanded (see topic 3) Manufacturer s License and Accreditation to Registration (see topic 4) Revision of QMS Ordinance QMS inspection per product family (see topic 4) 2nd Chapter became harmonized to ISO13485 (see topic 5) QMS inspection applied to Market Authorization Holder (MAH) (see topic 5.1) Issued on 1st April, 2015. 7

3. Type of QMS Inspection Issued on 1st April, 2015. 8

3.Type of QMS inspection QMS Inspections Application for approval Approval R&D Regulatory Review Marketing Every 5 years Pre-approval inspection Post-approval inspection Post-approval inspection One of the requirements for marketing approval of medical device Conducted every five years after obtaining marketing approval Based on application Conducted per Product Family Issued on 1st April, 2015. 9

Type of QMS Inspection 3.Type of QMS inspection 1. Pre-approval inspection Required before the marketing approval. 2. Pre-partial change approval inspection Required before the partial change approval. Inspection scope is MAH and the change-related sites. 3. Periodic post-approval inspection Required for maintaining marketing approval every 5 years since the initial marketing approval. 4. Additional inspection Required for the notified cases. ex) specialized inspection for biological products, micro machine and medical devices utilizing nano-materials etc.. Issued on 1st April, 2015. 10

QMS Inspection Authority 3.Type of QMS inspection Medical Devices IVDs Product Class IV New medical devices Cell / Tissue-based medical devices Class III and Class II (without CS*) Class III and Class II (with CS*) New drugs Radioactive drugs Products without CS* Products with CS* Inspection Authority PMDA Registered certification body PMDA Registered certification body *CS : Certification Standards Issued on 1st April, 2015. 11

4. Scope of mfg. site registration QMS inspection Issued on 1st April, 2015. 12

4.Scope of mfg. site registration and QMS inspection Manufacturing site Registration Sites listed below are required to register for each products. Site Design Facility Definition (1) maintain records of design and development, and (2) the responsible person should work here (1) mainly responsible for QMS or Main Assembling Plant product realization of the products, and (2) implement assembling(filling) processes. Sterilizer (1) implement sterilization process Domestic (Japan) Distribution Center (1) Storage and final release of the products to Japanese market. Issued on 1st April, 2015. 13

4.Scope of mfg. site registration and QMS inspection Scope of Registration and Inspection Registration QMS Inspection MAH Marketing Authorization Holder N/A The license of marketing is required Required Design Facility Required Required Main Assembling Plant Required Required Sterilizer Domestic (Japan) Distribution Center Other sites Required only for sterile medical device Required Not Required Required only for sterile medical device Required Depends PMDA determines based on risk assessment Issued on 1st April, 2015. 14

4.Scope of mfg. site registration and QMS inspection, and products Example of mfg. site registration in other country in Japan Design & Development Supplier Sub-Assembly Main Assembly Packing Distribution Shipping to the market Registration Required Not Required Not Required Required Not Required Required Issued on 1st April, 2015. 15

4.Scope of mfg. site registration and QMS inspection, and products Registration of Manufacturer [Before Revision] License, Accreditation [After Revision] Manufacturer needs Registration before the QMS inspection is conducted. License and Accreditation of manufacturer changed to Registration. BFR(Buildings and Facilities Regulation) conformity was one of the prerequisites for License and Accreditation, but now NOT for Registration. Licensing system Authority to provide license Before Revision License (Domestic) Accreditation (Foreign) Prefecture (Domestic) MHLW (Biological, Foreign) Registration After Revision Registration (Domestic, Foreign) Prefecture (Domestic) MHLW (Foreign) Category Requirements for licensing General, Sterilization, Biological, Packaging. Reasons for disqualification (Health, Crime, Revocation) Facilities requirement None Reasons for disqualification (Health, Crime, Revocation) None Issued on 1st April, 2015. 16

4.Scope of mfg. site registration and QMS inspection, and products Application Materials for Registration Application for Registration (Form No.63-5) Document that states an applicant is not intoxicated person Curriculum vitae of the representative in the facility Registered premises and/or areas with drawings and/or bird s eye-views Issued on 1st April, 2015. 17

4.Scope of mfg. site registration and QMS inspection, and products Product Families QMS inspection is conducted per Product Family Generic names of Medical Devices and IVDs are grouped into Product Families depending on factors such as mfg. process, characteristics, usage method, risk etc.. Product Family A Generic Name 1 Generic Name 2 Generic Name 3 Product Family B Generic Name 11 Generic Name 12 Generic Name 13 Product Family consists of some Generic Names The relationship between product family and generic name will be announced by notification [1] Issued on 1st April, 2015. 18

4.Scope of mfg. site registration and QMS inspection, and products Exception of Product Families However Products having generic names not grouped into product family: QMS inspection per generic name High risk product: QMS inspection per product (specified in public notice [2]) Issued on 1st April, 2015. 19

4.Scope of mfg. site registration and QMS inspection, and products QMS Inspection is conducted per Medical Devices and In-Vitro Diagnostics(Class II~IV) per Product (High risk Product) per Generic name (not grouped into product family) per Product Family Issued on 1st April, 2015. 20

4.Scope of mfg. site registration and QMS inspection, and products Product Families Product Families: Class IV Class IV Product Family is established by Japanese original definition. Examples of product families: Stent Stent graft Active catheter Cardiac pacemaker and defibrillator Ventricular assist device Product Families: Class II / III Class II / III Product Family refer to NBOG BPG 2009-3. Examples of product families: Non-active instruments (MD 0106) Non-active cardiovascular implants (MD 0201) Non-active dental equipment and instruments (MD 0401) Devices for stimulation or inhibition (MD 1103) Imaging devices utilizing ionizing radiation (MD 1201) Issued on 1st April, 2015. 21

5. QMS Inspection Issued on 1st April, 2015. 22

Revision of QMS Ordinance 5.QMS inspection Before Revision marketing approval manufacturer accreditation marketing license QMS ordinance (ISO13485 + Additional Requirements) Building and Facility Regulation GQP ordinance Harmonized to ISO13485 After Revision Chapter 2 Additional Requirements Chapter 3 Chapter 4,5 Chapter 6 New QMS ordinance Outsourcing, etc. Chapter 4 and 5 provide for requirements of building and facility for manufacturer of biological medical devices and radioactive IVDs. QMS organization ordinance Issued on 1st April, 2015. 23

5.QMS inspection Contents of New QMS ordinance Chapter Title Article 1 General Provisions 1~3 2 Medical Devices Manufacturing Harmonized to ISO13485:2003 4~64 3 Additional Requirements. 65~72-3 4 5 6 Biological-origin Medical Device, etc. Manufacturers (Domestic, Foreign) 73~79 Additional requirements according to the characteristics of the products In-Vitro Diagnostic Radioactive Reagents Manufacturers(Domestic, Foreign) 80~81 Additional requirements according to the characteristics of the products Provisions Applied Mutatis Mutandis of Medical Device, etc. Manufacturing Sites, etc. 82~84 Issued on 1st April, 2015. 24

5.QMS inspection Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 25

5.1.Application of QMS inspection Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 26

Documents for QMS application 5.1.Application of QMS inspection No. Documents Scope Pre-Approval/ Pre-Partial Postapproval 1 ISO13485 Certification, registered certification body s Inspection report, etc Mfg. sites Required Required 2 Manufacturing process flow Product subject to inspection Required Required 3 Outline of content of mfg. site s activities and documents which can identify mutual relations of QMS between MAH and mfg. sites. Mfg. sites Required Required 4 Outline of mfg. site Mfg. sites Required Required 5 Product list for application Product family Required Required Issued on 1st April, 2015. 27

5.2.Determination of on-site or desktop inspection Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 28

5.2.Determination of on-site or desktop inspection Decision of desktop or on-site Input Information Risk Assessment Submitted documents Reported adverse events and recalls Records of previous QMS inspections etc. Complexity of manufacturing processes Risk associated with the use of products Previous nonconformities and recalls Results of the previous on-site inspections Certificate of ISO13485 etc. Decision of on-site or desktop On-Site Inspection Desktop Inspection Issued on 1st April, 2015. 29

5.2.Determination of on-site or desktop inspection High possibility of desktop inspection If MAH or Mfg. sites have (1) Latest ISO13485 certification or audit report within 3 years of issue. issued by certification bodies registered under the medical device regulation system of Japan, US, Europe, Australia or Canada. (2) Latest On-site QMS inspection report within 3 years of issue by registered certification bodies in Japan (3) QMS inspection report issued by the foreign governments under MOU, etc. Issued on 1st April, 2015. 30

5.3.On-site inspection Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 31

On-site inspection flow chart 5.3.On-site inspection Notification of Inspection Mfg. site ~6 weeks 3~4 days ~14days ~30 days* Submit documents PMDA requests On-site QMS Inspection Issue findings report Submit improvement Plan or Report ~4 months Accept improvement Plan or Report Issued on 1st April, 2015. 32

Overseas on-site inspection 2 inspectors / inspection in general Accompanied by interpreters Duration : 2 to 4 days Notification : ~ 6 weeks before the inspection Scope : Product Family (Not only application product, but also products in same product family are subject to QMS Inspection.) Request for documents prior to the inspection 5.3.On-site inspection Issued on 1st April, 2015. 33

5.3.On-site inspection Example of QMS Inspection Schedule Date Time Item Day 1 9:00~12:00 1.Opening meeting (1) Introduction of Inspection (2) Overview of Company and Facility* (3) Overview of Products* (4) Changes (QMS) from the last Inspection* 13:00~17:00 4. Plant tour 2. Management (1) QMS organization (including Agreement made with MAH (2) Quality Manual (3) Quality Policy and Objectives (4) Management Review 3. Documentation and Records Day 2 9:00~12:00 5. Product and Process controls 6. Product documentation (Seihin Hyojun Syo) 13:00~17:00 7. Design and Development (including Risk Management) Day 3 9:00~12:00 8. Purchasing Control 9. Customer related processes 13:00~17:00 10. Corrective and Preventive Actions 11. Teem Meeting of Inspectors 12. Confirmation on Findings 13. Closing Meeting As to items with*, Please give presentations to Inspectors. Note that this schedule may slightly change due to progress. Issued on 1st April, 2015. 34

5.3.On-site inspection Documents to be submitted for on-site inspection Request for Submitted Documents for On-site Inspection (ex) Quality Manual List of QMS documents Quality control process chart CAPA log in English or Japanese Issued on 1st April, 2015. 35

5.4.Desktop inspection Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 36

Documents about product subject to the Inspection Documents about QMS Documents about subject of QMS Inspection mfg. site Documents for QMS desktop review 5.4.Desktop inspection Documents Outline of Documents Subject Layout of all mfg. site building Floor plan Organization chart Quality management system List of documents identified with QMS Seihin Hyojun Sho Validation status of mfg. process Aerial photograph or location map of mfg. site Clean room grade Differential pressure List or layout of representative manufacturing and inspection equipments Responsible persons and departments related to QMS Mfg. sites (expect for Design facility) Mfg. sites (expect for Design facility) Pre-/ Pre-partial required required Post-approval required required Mfg. sites required Required Quality Manual Mfg. sites required required Including name, number, and retention period of QMS control documents Seihin Hyojun Syo is document which showed the location of documents required by QMS.(Device master record OK) Reference:Aug27, 2014 PFSB/CND No.0827-2 List showing mfg process, mfg. site, and date about the validation. Mfg. sites required Required Product subject to Inspection Product subject to Inspection required required required required Issued on 1st April, 2015. 37

5.4.Desktop inspection Cases from desktop to on-site inspection We may change desktop inspection to on-site inspection in the following cases as needed. If there is no response or the response is not satisfactory The documents are not in order, and haven't improved Issued on 1st April, 2015. 38

5.5.Conformity assessment Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 39

Grading of Nonconformities 5.5.Conformity assessment Figure 1:Grading overview Figure 2:Grading matrix Nonconformity Step1 Grading matrix Step2 Escalation Rules 3 4 1 2 First Repeat Occurrence Direct Indirect QMS Impact Nonconformity Grade Reference:GHTF/SG3/N19:2012 Direct QMS Impact Article 25 to 65, 69, 72, 73, 75, 76, 80, 81, 84 Indirect QMS Impact Article 5 to 24, 66 to 68, 70, 71, 72-2, 74, 77 to 79 Issued on 1st April, 2015. 40

5.5.Conformity assessment QMS compliance evaluation(1/2) Only Grade 1 Evaluation:Conformity Inspection ~14 days Findings Report ~about 30 days Fixed date Improvement Report/Plan Audit Report Confirmation of the effectiveness Next Inspection Grade 2, 3 Improvement Reporting Date < Fixed date Evaluation:Conformity > Fixed date Evaluation:Nonconformity Inspection ~14 days Findings Report ~about 30 days Fixed date Improvement Report Audit Report Confirmation of the effectiveness Next Inspection Issued on 1st April, 2015. 41

5.5.Conformity assessment QMS compliance evaluation(2/2) More than Grade 4 Findings Report Audit Report Confirmation of the effectiveness Inspection ~14 days Within 15 days Improvement Report Next Inspection Evaluation:Nonconformity Improvement Reporting Date < 15 Evaluation:Conformity > 15Evaluation:Nonconformity Issued on 1st April, 2015. 42

Final assessment 5.5.Conformity assessment If all sites are conformity If mfg. site B is nonconformity Mfg. site A Mfg. site B Mfg. site C Mfg. site A Mfg. site B Mfg. site C Design Facility Assembling plant Distribution center Design Facility Assembling plant Distribution center MAH MAH Conformity for application conformity nonconformity MAH is nonconformity, too. (Reference: QMS ordinance article 65) Nonconformity for application Issued on 1st April, 2015. 43

5.5.Conformity assessment Overview of QMS inspection flow Receive application of QMS inspection ~4 week Determine on-site or desktop inspection ~4 month On-site Inspection Desktop Inspection MAH * Mfg. site A * (Assembly) Mfg. site B * (Design) Mfg. site C * (Distribution) Conformity assessment ~4 week Issue Compliance certification and inspection report *: Example. PMDA determines whether on-site or desktop inspection based on risk assessment. See 5.2.. 6 months Issued on 1st April, 2015. 44

5.5.Conformity assessment QMS Compliance Certification QMS Compliance Certification Summary Report Marketing Authorization Holder Manufacturing Site (Design Facility) Desktop 実地調査 Inspection On-site Inspection Inspection Report Assembling Plant Manufacturing Site (Assembling Plant) Manufacturing Site (Contract Sterilizer) On-site Inspection Desktop Inspection Inspection Report* *Send to MAH, in a general. Manufacturing Site (Domestic Distribution Center) Desktop 書面調査 Inspection Issued on 1st April, 2015. 45

Summary Report 5.5.Conformity assessment Reporting Date: QMS summary report [Inspecting organization] Lead inspector: Inspector: Inspection Report Inspection Report Inspection Report 1. Reference No. 2. General Information (1) Name of the MAH (2) Address of the MAH (3) Products under the inspection (4) Purpose of the inspection Summary Report 3. Summary of result of each mfg. sites (1) Name of the mfg. site (2) Address of the mfg. site (3) Registration number and date (4) Sub-systems under the inspection (5) Inspecting date (6) On-site or desktop (7) Reference no. of QMS inspection report (8) Result of the inspection 4. Total result 5. Recital Issued on 1st April, 2015. 46

References References [1] [2] MHLW Compliance and Narcotics Division on September 11, 2014 as notification No. 5 MHLW on August 6, 2014 as Notice 317 QMS regulation-related sites PMDA / QMS (English) http://www.pmda.go.jp/english/review-services/gmp-qms-gctp/0002.html PMDA / Notifications related to PAL Revision (Japanese) http://www.pmda.go.jp/review-services/drug-reviews/aboutreviews/devices/8077.html MHLW (English) http://www.mhlw.go.jp/english/index.html Issued on 1st April, 2015. 47